CHROMOCELL THERAPEUTICS CORPORATION

Altre lingue Chromocell Therapeutics Corporation

Azioni

CHRO

US1711261057

Mercato chiuso - Nyse Altri mercati azionari 22:10:00 24/05/2024			Variaz. 5gg	Var. 1 gen.
1,434 ^USD	+1,00%		-18,05%	0,00%

15/05	Chromocell Therapeutics Corporation riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
16/04	Chromocell Therapeutics Corporation riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024	13/05
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024	13/05
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Chromocell Issues Letter to Stockholders from Chief Executive Officer	09/04
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler	21/03
Chromocell Therapeutics Corporation Announces Formal Launch of Eye Pain Treatment Program	21/03
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023	18/03
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023	18/03
Chromocell Therapeutics Corp. Appoints Frank Knuettel, Interim CEO, as Permanent CEO	18/03
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14	11/03
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14	11/03
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions	27/02
Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million	21/02
Chromocell Therapeutics Corporation has completed an IPO in the amount of $6.6 million.	15/02
Chromocell Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/01
Chromocell Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	01/09/23
Chromocell Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	30/06/23
Chromocell Therapeutics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	01/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Borsa valori
Azioni
Azione CHRO
Notizie Chromocell Therapeutics Corporation
Altre lingue

-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.

APPROFITTANE ORA